Union Bankshares Corporation to Release First Quarter 2017 Results
Apr 04, 2017 17:01 pm UTC| Business
RICHMOND, Va., April 04, 2017 -- Union Bankshares Corporation today announced that it will release its first quarter 2017 financial results before the market opens on Wednesday, April 19, 2017. Following the release,...
Apr 04, 2017 17:01 pm UTC| Business
NEW YORK, April 04, 2017 -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the first presentation of preclinical data on the Company’s novel fully human anti-PD-L1 monoclonal antibody at the American Association...
Apr 04, 2017 17:01 pm UTC| Business
NEW YORK, April 04, 2017 -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the first presentation of preclinical data on the Company’s novel fully human anti-PD-L1 monoclonal antibody at the American Association...
Apr 04, 2017 17:00 pm UTC| Business
Selinexor Achieves Robust and Prolonged Response Rates in Patients with Relapsed or Refractory DLBCL, Including Against Both GCB and Non-GCB Subtypes 28.6% Overall Response Rate Demonstrated with a Median Duration of...
Gentex Reports First Quarter 2017 Earnings Release Date and Conference Call
Apr 04, 2017 17:00 pm UTC| Business
ZEELAND, Mich., April 04, 2017 -- Gentex Corporation (NASDAQ:GNTX), the Zeeland, Michigan-based manufacturer of automotive automatic-dimming rearview mirrors, automotive electronics, dimmable aircraft windows and fire...
Checkpoint Therapeutics Reports Preclinical Data for Two Oncology Programs
Apr 04, 2017 17:00 pm UTC| Business
NEW YORK, April 04, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that preclinical data on its third-generation epidermal growth factor...
Apr 04, 2017 17:00 pm UTC| Business
WASHINGTON, April 04, 2017 -- Immunomedics, Inc., (NASDAQ:IMMU) (“Immunomedics” or “the Company”) today reported that labetuzumab govitecan (IMMU-130), the Company’s second investigational agent from its award-winning...